International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors.
Saved in:
| Title: | International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors. |
|---|---|
| Authors: | Alexander SPH; Division of Physiology, Pharmacology and Neuroscience, Life Sciences, University of Nottingham Medical School, Nottingham, United Kingdom. Electronic address: steve.alexander@nottingham.ac.uk., Bennett KA; Nxera Pharma UK Ltd, Cambridge, United Kingdom., Brown AJ; Ikherma Consulting Ltd, Hertfordshire, United Kingdom., Glass M; School of Pharmacy and Pharmacology, University of Otago, Otago, New Zealand., Gloriam DE; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Hanson J; Laboratory of Molecular Pharmacology, GIGA Research Institute and Center of Interdisciplinary Research on Medicine, University of Liège, Liège, Belgium., Insel PA; Departments of Pharmacology and Medicine, University of California, San Diego, La Jolla, California., Kelly E; School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom., Langmead CJ; Drug Discovery Biology and Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Martemyanov KA; Department of Physiology and Biophysics, University of Miami Miller School of Medicine, Miami, Florida., Neubig RR; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan and Nicholas V. Perricone, MD, Division of Dermatology, Department of Medicine, College of Human Medicine, East Lansing, Michigan., Offermanns S; Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim Germany and Center for Molecular Medicine, Goethe-University Frankfurt, Frankfurt am Main, Germany., Rosenkilde MM; Department of Biomedical Sciences, Lab for Molecular Pharmacology, University of Copenhagen, Copenhagen, Denmark., Schulte G; Department Physiology and Pharmacology, Section of Receptor Biology and Signaling, Karolinska Institutet, Stockholm Sweden., Smith NJ; Orphan Receptor Laboratory, Department of Pharmacology, School of Biomedical Sciences, Faculty of Medicine & Health, UNSW Sydney, Sydney, Australia., Wu H; Medicine Design, Pfizer Research and Development, Pfizer Inc, Groton, Connecticut., Faccenda E; Institute for Neuroscience and Cardiovascular Research, College of Medicine & Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom., Harding SD; Institute for Neuroscience and Cardiovascular Research, College of Medicine & Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom., Davenport AP; Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Level 6, Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, United Kingdom. |
| Source: | Pharmacological reviews [Pharmacol Rev] 2026 May 08; Vol. 78 (4), pp. 100141. Date of Electronic Publication: 2026 May 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: Netherlands NLM ID: 0421737 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0081 (Electronic) Linking ISSN: 00316997 NLM ISO Abbreviation: Pharmacol Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42269381 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Alexander+SPH%22">Alexander SPH</searchLink>; Division of Physiology, Pharmacology and Neuroscience, Life Sciences, University of Nottingham Medical School, Nottingham, United Kingdom. Electronic address: steve.alexander@nottingham.ac.uk.<br /><searchLink fieldCode="AU" term="%22Bennett+KA%22">Bennett KA</searchLink>; Nxera Pharma UK Ltd, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Brown+AJ%22">Brown AJ</searchLink>; Ikherma Consulting Ltd, Hertfordshire, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Glass+M%22">Glass M</searchLink>; School of Pharmacy and Pharmacology, University of Otago, Otago, New Zealand.<br /><searchLink fieldCode="AU" term="%22Gloriam+DE%22">Gloriam DE</searchLink>; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Hanson+J%22">Hanson J</searchLink>; Laboratory of Molecular Pharmacology, GIGA Research Institute and Center of Interdisciplinary Research on Medicine, University of Liège, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Insel+PA%22">Insel PA</searchLink>; Departments of Pharmacology and Medicine, University of California, San Diego, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Kelly+E%22">Kelly E</searchLink>; School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Langmead+CJ%22">Langmead CJ</searchLink>; Drug Discovery Biology and Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Martemyanov+KA%22">Martemyanov KA</searchLink>; Department of Physiology and Biophysics, University of Miami Miller School of Medicine, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Neubig+RR%22">Neubig RR</searchLink>; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan and Nicholas V. Perricone, MD, Division of Dermatology, Department of Medicine, College of Human Medicine, East Lansing, Michigan.<br /><searchLink fieldCode="AU" term="%22Offermanns+S%22">Offermanns S</searchLink>; Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim Germany and Center for Molecular Medicine, Goethe-University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Rosenkilde+MM%22">Rosenkilde MM</searchLink>; Department of Biomedical Sciences, Lab for Molecular Pharmacology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Schulte+G%22">Schulte G</searchLink>; Department Physiology and Pharmacology, Section of Receptor Biology and Signaling, Karolinska Institutet, Stockholm Sweden.<br /><searchLink fieldCode="AU" term="%22Smith+NJ%22">Smith NJ</searchLink>; Orphan Receptor Laboratory, Department of Pharmacology, School of Biomedical Sciences, Faculty of Medicine & Health, UNSW Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; Medicine Design, Pfizer Research and Development, Pfizer Inc, Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Faccenda+E%22">Faccenda E</searchLink>; Institute for Neuroscience and Cardiovascular Research, College of Medicine & Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Harding+SD%22">Harding SD</searchLink>; Institute for Neuroscience and Cardiovascular Research, College of Medicine & Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Davenport+AP%22">Davenport AP</searchLink>; Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Level 6, Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220421737%22">Pharmacological reviews</searchLink> [Pharmacol Rev] 2026 May 08; Vol. 78 (4), pp. 100141. <i>Date of Electronic Publication: </i>2026 May 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Pharmacology+and+Experimental+Therapeutics%22">American Society for Pharmacology and Experimental Therapeutics </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0421737 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1521-0081 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200316997%22">00316997 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacol Rev <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42269381 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.pharmr.2026.100141 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100141 Titles: – TitleFull: International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alexander SPH – PersonEntity: Name: NameFull: Bennett KA – PersonEntity: Name: NameFull: Brown AJ – PersonEntity: Name: NameFull: Glass M – PersonEntity: Name: NameFull: Gloriam DE – PersonEntity: Name: NameFull: Hanson J – PersonEntity: Name: NameFull: Insel PA – PersonEntity: Name: NameFull: Kelly E – PersonEntity: Name: NameFull: Langmead CJ – PersonEntity: Name: NameFull: Martemyanov KA – PersonEntity: Name: NameFull: Neubig RR – PersonEntity: Name: NameFull: Offermanns S – PersonEntity: Name: NameFull: Rosenkilde MM – PersonEntity: Name: NameFull: Schulte G – PersonEntity: Name: NameFull: Smith NJ – PersonEntity: Name: NameFull: Wu H – PersonEntity: Name: NameFull: Faccenda E – PersonEntity: Name: NameFull: Harding SD – PersonEntity: Name: NameFull: Davenport AP IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 05 Text: 2026 May 08 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1521-0081 Numbering: – Type: volume Value: 78 – Type: issue Value: 4 Titles: – TitleFull: Pharmacological reviews Type: main |
| ResultId | 1 |
